ConductScience.org, home

Paper39636638

Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.

Back AL and 14 others. JAMA Netw Open, 2024. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial. Papers, record 39636638. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39636638

Download JSON
Disease
depressive disorder301 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.
PubMed
Journal
JAMA Netw Open
PubMed
Year
2024
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
7.72, provisional
iCite
Revised in PubMed
2025-07-16
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Back ALAnthony L
2Freeman-Young TKTimara K
3Morgan LLadybird
4Sethi TTanmeet
5Baker KKKelsey K
6Myers SSusanna
7McGregor BABonnie A
8Harvey KKalin
9Tai MMarlene
10Kollefrath AAustin
11Thomas BJBrandon J
12Sorta DDennis
13Kaelen MMendel
14Kelmendi BBenjamin
15Gooley TATed A

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Burnout, ProfessionalMajor topic
COVID-19Major topic
DepressionMajor topic
PsilocybinMajor topic
Stress Disorders, Post-TraumaticMajor topic
Adult
Female
Humans
Male
Middle Aged
Double-Blind Method
Hallucinogens
Pandemics
Treatment Outcome

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
UL1 TR001863NCATS NIH HHSUnited StatesUL1TR001863PubMed

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05163496Frontline Clinician Psilocybin StudyDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Erratum in39804652Error in the Byline.https://conductscience.org/library/papers/39804652PubMed
Erratum in40638123Errors in the Author Affiliations.https://conductscience.org/library/papers/40638123PubMed

Download CSV of comments and corrections

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134941354Reliable and clinically significant change in the clinician-administered PTSD Scale for DSM-5 and PTSD Checklist for DSM-5 among male veterans.Psychol Assess2022https://conductscience.org/library/papers/34941354PubMed
229396616The hidden therapist: evidence for a central role of music in psychedelic therapy.Psychopharmacology (Berl)2018https://conductscience.org/library/papers/29396616PubMed
336931567The prevalence of probable mental health disorders among hospital healthcare workers during COVID-19: A systematic review and meta-analysis.J Affect Disord2023https://conductscience.org/library/papers/36931567PubMed
434778184Burnout Among Healthcare Workers in the COVID 19 Era: A Review of the Existing Literature.Front Public Health2021https://conductscience.org/library/papers/34778184PubMed
534918181The Impact of the COVID-19 Pandemic on Mental Health, Occupational Functioning, and Professional Retention Among Health Care Workers and First Responders.J Gen Intern Med2022https://conductscience.org/library/papers/34918181PubMed
629446697Psychedelics and the essential importance of context.J Psychopharmacol2018https://conductscience.org/library/papers/29446697PubMed
729196982
A Brief Instrument to Assess Both Burnout and Professional Fulfillment in Physicians: Reliability and Validity, Including Correlation with Self-Reported Medical Errors, in a Sample of Resident and Practicing Physicians.
Acad Psychiatry2018https://conductscience.org/library/papers/29196982PubMed
833249552Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depression.Acta Psychiatr Scand2021https://conductscience.org/library/papers/33249552PubMed
937651119Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA2023https://conductscience.org/library/papers/37651119PubMed
1033881489Navigating Attacks Against Health Care Workers in the COVID-19 Era.JAMA2021https://conductscience.org/library/papers/33881489PubMed
1138316896Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.Sci Rep2024https://conductscience.org/library/papers/38316896PubMed
1222308440Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22308440PubMed
1337064688The relationship between physician burnout and depression, anxiety, suicidality and substance abuse: A mixed methods systematic review.Front Public Health2023https://conductscience.org/library/papers/37064688PubMed
1436921889Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.Neuropharmacology2023https://conductscience.org/library/papers/36921889PubMed
1533146667Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.JAMA Psychiatry2021https://conductscience.org/library/papers/33146667PubMed
1627909165Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.J Psychopharmacol2016https://conductscience.org/library/papers/27909165PubMed
1727080628Clinical research and methodology: What usage and what hierarchical order for secondary endpoints?Therapie2016https://conductscience.org/library/papers/27080628PubMed
1832725172The Current Status of Psychedelics in Psychiatry.JAMA Psychiatry2021https://conductscience.org/library/papers/32725172PubMed
1918174510Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale (SIGMA).Br J Psychiatry2008https://conductscience.org/library/papers/18174510PubMed
2026606250The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation.J Trauma Stress2015https://conductscience.org/library/papers/26606250PubMed

See all 33 referencesDownload CSV of references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
42663293Natural medicine‑empowered treatment of depression via restoring neurogenesis (Review).Mol Med Rep2026https://conductscience.org/library/papers/42663293PubMed
42652397Interventions to Support the Mental Health of Frontline Healthcare Workers During the COVID-19 Pandemic: A Systematic Review.Int J Environ Res Public Health2026https://conductscience.org/library/papers/42652397PubMed
42645703Next-Generation Pharmacotherapies for Unipolar Mood Disorders: A Leading Article on Phase II/III Drug Development Across Diverse Mechanisms.CNS Drugs2026https://conductscience.org/library/papers/42645703PubMed
42541603Psilocybin for Fear of Cancer Recurrence.Support Care Cancer2026https://conductscience.org/library/papers/42541603PubMed
42182826The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus.Front Behav Neurosci2026https://conductscience.org/library/papers/42182826PubMed
42036582Psychedelics: Future Therapeutics in Major Depression?Adv Exp Med Biol2026https://conductscience.org/library/papers/42036582PubMed
41997697Measuring and appraising placebo effects in clinical trials: contemporary challenges and approaches in psychiatry.Lancet Psychiatry2026https://conductscience.org/library/papers/41997697PubMed
41876707Anesthetics as emerging therapeutics for post-traumatic stress disorder (PTSD): bridging bench and bedside.Mol Psychiatry2026https://conductscience.org/library/papers/41876707PubMed
41805956Psilocybin or Nicotine Patch for Smoking Cessation: A Pilot Randomized Clinical Trial.JAMA Netw Open2026https://conductscience.org/library/papers/41805956PubMed
41705428Magnitude of response in treatment and control groups within psychedelic trials for psychiatric disorders: A meta-analysis.Eur Psychiatry2026https://conductscience.org/library/papers/41705428PubMed
41563753Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.JAMA Netw Open2026https://conductscience.org/library/papers/41563753PubMed
41369360Psychedelics in Multiple Sclerosis: Mechanisms, Challenges, and Prospects for Neuroimmune Modulation and Repair.Cells2025https://conductscience.org/library/papers/41369360PubMed
41178084Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review.BJPsych Open2025https://conductscience.org/library/papers/41178084PubMed
41103742Oxytocin administration to clinicians in acute psychiatric care settings: a feasibility study.Front Psychiatry2025https://conductscience.org/library/papers/41103742PubMed
40972137Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial.PLoS Med2025https://conductscience.org/library/papers/40972137PubMed
40969466Psychedelic training program development: lessons from the evolution of the EMBARK program.Front Psychol2025https://conductscience.org/library/papers/40969466PubMed
40691651"I've learned that I'm open-minded to this possibility": A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke.Addict Sci Clin Pract2025https://conductscience.org/library/papers/40691651PubMed
40638123Errors in the Author Affiliations.JAMA Netw Open2025https://conductscience.org/library/papers/40638123PubMed
40283990The Emergence of Psilocybin in Psychiatry and Neuroscience.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40283990PubMed
40282849Pharmacological Monotherapy for Depressive Disorders: Current and Future-A Narrative Review.Medicina (Kaunas)2025https://conductscience.org/library/papers/40282849PubMed

See all 23 cited byDownload CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
PSILOCYBINCHEMBL194378Derived from the trial1https://conductscience.org/library/drugs/CHEMBL194378

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39636638

GET https://conductscience.org/api/papers/v1/39636638/references?page=2